Skip to main content

Catecholamine Deficiency

  • Reference work entry
Encyclopedia of Molecular Mechanisms of Disease
  • 244 Accesses

Synonyms

Relevant conditions: Pure autonomic failure; PAF; Idiopathic orthostatic hypotension or Bradbury-Eggleston syndrome; Multiple system atrophy; MSA or Shy-Drager syndrome; Familial dysautonomia or Riley-Day syndrome (FD); Atypical phenylketonuria (PKU) or dihydropteridine (BH4) reductase deficiency; Segawa disease or dopa-responsive dystonia; Tyrosine hydroxylase deficiency (TH); Aromatic L-amino acid decarboxylase (DDC) deficiency; Dopamine β-hydroxylase deficiency DBH; Menkes disease

Definition and Characteristics

Most can be classified as dysautonomias; conditions in which altered function of the autonomic nervous system adversely affects health [1]. Dysautominias range from common transient episodes in otherwise healthy people (e.g., neurocardiogenic syncope), to more rare and severe conditions associated with deficiencies of catecholamines resulting from progressive neurodegenerative diseases (e.g., PAF) or rare genetic disorders involving loss of function of enzymes...

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 1,099.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 1,299.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Goldstein DS, Robertson D, Esler M, Straus SE, Eisenhofer G (2002) Dysautonomias: clinical disorders of the autonomic nervous system. Ann Intern Med 137:753–763

    PubMed  Google Scholar 

  2. Robertson D, Beck C, Gary T, Picklo M (1993) Classification of autonomic disorders. Int Angiol 12:93–102

    PubMed  CAS  Google Scholar 

  3. Kim CH, Zabetian CP, Cubells JF, Cho S, Biaggioni I, Cohen BM, Robertson D, Kim KS (2002) Mutations in the dopamine beta-hydroxylase gene are associated with human norepinephrine deficiency. Am J Med Genet 108:140–147

    Article  PubMed  Google Scholar 

  4. Goldstein DS, Lenders JW, Kaler SG, Eisenhofer G (1996) Catecholamine phenotyping: clues to the diagnosis, treatment, and pathophysiology of neurogenetic disorders. J Neurochem 67:1781–1790

    PubMed  CAS  Google Scholar 

  5. Pearl PL, Hartka TR, Taylor J (2006) Diagnosis and treatment of neurotransmitter disorders. Curr Treat Options Neurol 8:441–450

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer-Verlag GmbH Berlin Heidelberg

About this entry

Cite this entry

Eisenhofer, G. (2009). Catecholamine Deficiency. In: Lang, F. (eds) Encyclopedia of Molecular Mechanisms of Disease. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-29676-8_297

Download citation

Publish with us

Policies and ethics